Issue 15, 2022

Self-assembly of DNA nanogels with endogenous microRNA toehold self-regulating switches for targeted gene regulation therapy

Abstract

Herein, a smart nanohydrogel with endogenous microRNA-21 toehold is developed to encapsulate gemcitabine-loaded mesoporous silica nanoparticles for targeted pancreatic cancer therapy. This toehold mediated strand displacement method can simultaneously achieve specific drug release and miRNA-21 silencing, resulting in the up-regulation of the expression of tumor suppressor genes PTEN and PDCD4.

Graphical abstract: Self-assembly of DNA nanogels with endogenous microRNA toehold self-regulating switches for targeted gene regulation therapy

Supplementary files

Article information

Article type
Communication
Submitted
25 Apr 2022
Accepted
18 Jun 2022
First published
20 Jun 2022
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2022,10, 4119-4125

Self-assembly of DNA nanogels with endogenous microRNA toehold self-regulating switches for targeted gene regulation therapy

J. Yan, H. Zou, W. Zhou, X. Yuan, Z. Li, X. Ma, C. Liu, Y. Wang, J. M. Rosenholm, W. Cui, X. Qu and H. Zhang, Biomater. Sci., 2022, 10, 4119 DOI: 10.1039/D2BM00640E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements